- Home
- CCC vs PTGX Comparison
CCC vs PTGX Comparison
Compare CCC & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$8.07
HOLD
Current Price
$89.42
Company Overview
Basic Information| Metric | CCC | PTGX |
|---|---|---|
| Founded | 1980 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 5.4B |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | CCC | PTGX |
|---|---|---|
| Price | $8.07 | $89.42 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 9 |
| Target Price | $8.00 | ★ $90.56 |
| AVG Volume (30 Days) | ★ 7.0M | 982.6K |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.72 |
| Revenue | ★ $1,025,600,000.00 | $209,217,000.00 |
| Revenue This Year | $12.72 | N/A |
| Revenue Next Year | $9.30 | $288.98 |
| P/E Ratio | ★ N/A | $123.27 |
| Revenue Growth | ★ 10.64 | N/A |
| 52 Week Low | $6.96 | $33.70 |
| 52 Week High | $11.96 | $96.54 |
Technical Indicators
Market Signals| Indicator | CCC | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 55.09 |
| Support Level | N/A | $84.11 |
| Resistance Level | N/A | $90.00 |
| Average True Range (ATR) | 0.00 | 3.27 |
| MACD | 0.00 | -0.65 |
| Stochastic Oscillator | 0.00 | 41.92 |
Price Performance
Historical Comparison CCC
PTGX
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.